Patient Condition and History
Mya is a 14-year-old spayed female domestic shorthair cat, weighing 13 lb, who lives exclusively indoors and had no previously known medical issues. Her owner, Carol Pipher, a veterinary technician at Southern Tier Veterinary Associates in Vestal, NY, fitted Mya with a PetPace collar as part of routine health screening and monitoring at home. Because Carol works in veterinary medicine, she was attentive to the collar’s reports and to changes in Mya’s baseline measurements.
Monitoring Data and Medical Exam
The PetPace collar recorded heart and activity data that prompted concern: Mya’s average pulse was markedly elevated at 182 beats per minute, with a recorded maximum of 231 and a minimum of 130. The collar also showed a low heart rate variability (VVTI of 8.2), a non-specific indicator that can reflect physiologic stress or illness. Based on these abnormal trend data, Carol brought Mya to the clinic for a veterinary evaluation.
On physical examination Mya appeared clinically unremarkable, but routine bloodwork revealed a significantly elevated thyroid hormone (T4 of 12.4 µg/dL; reference range 0.8–4.7 µg/dL) and a mildly high red blood cell count (RBC 11.6 million/µL; reference range 7.12–11.4 million/µL). These laboratory findings are commonly associated with feline hyperthyroidism and supported the need for treatment, even in the absence of obvious clinical signs at that time.
Mya was started on oral medication to control her excess thyroid hormone. The treatment effectively reduced her T4 levels and produced measurable changes in the physiologic data recorded by the collar. A 24-hour follow-up monitoring session three months after the start of therapy showed substantial improvement: average pulse values fell by roughly 20% (average 141; max 208; min 103) and heart rate variability improved by about 13% (VVTI 9.3), consistent with clinical response to treatment and stabilization of her metabolic state.
ELEVATED PULSE INDEXES IN A CAT WITH OCCULT HYPERTHYROIDISM.
SIGNIFICANT DECREASES IN PULSE INDEXES FOLLOWING MEDICAL TREATMENT FOR HYPERTHYROIDISM.
Discussion
Hyperthyroidism in cats is caused by excessive production of thyroid hormones from the thyroid glands and is one of the most common endocrine disorders in older felines. Thyroid hormones influence metabolism and many organ systems, so the disease can affect appetite, weight, cardiovascular function, behavior and more. Clinical signs may be subtle at first and often develop gradually, which means cases can remain undetected until the disease is well advanced. Left untreated, hyperthyroidism can lead to significant health consequences, including persistent weight loss, cardiac changes and potential secondary organ damage.
This case illustrates how objective, continuous monitoring can detect physiologic trends that alert owners and veterinarians to a developing problem before severe clinical signs appear. In Mya’s situation, the collar identified elevated heart rates and low heart rate variability—findings that justified further diagnostic testing. Laboratory confirmation then allowed timely initiation of medical therapy that reduced thyroid hormone levels and improved cardiovascular parameters, as documented by both blood tests and subsequent collar data.
The value of early detection in chronic, slowly progressive diseases cannot be overstated. Owners may miss subtle day-to-day changes in an aging pet, and even attentive caregivers can overlook early indicators that are visible only through continuous or trend-based monitoring. Devices that aggregate and analyze physiological measurements over time can expose non-specific deviations from baseline—changes that warrant veterinary follow-up and targeted diagnostics.
Conclusions
The PetPace collar can provide early, actionable indications of changing health in individual pets by tracking trends in heart rate, heart rate variability and activity. In this case, data from the collar led to a veterinary examination, laboratory testing, a diagnosis of hyperthyroidism and prompt initiation of treatment, all before advanced complications developed. The collar also documented objective improvement after therapy, demonstrating its usefulness for both screening and monitoring response to treatment.
Many chronic conditions in cats progress insidiously, and symptoms are often noticed late in the disease course. Incorporating non-invasive trend monitoring into routine care can help veterinarians and owners detect problems earlier, prioritize diagnostic work-ups and intervene sooner, which can improve outcomes and reduce the risk of irreversible organ damage.
Dr. Cari Bowlin, Medical Director at Southern Tier Veterinary Associates, observed that collar-generated data prompted a thorough examination of a cat that initially appeared healthy, enabling a timely diagnosis and reinforcing clinician confidence in the technology. Dr. Asaf Dagan, PetPace’s Chief Veterinarian and a board-certified clinician, noted that routine screening using such monitoring tools could be integrated into annual wellness plans to improve early detection of chronic illnesses and ultimately enhance pet health and longevity.